首发精神病患者脑源性神经营养因子水平的系统评价。
Brain-derived neurotrophic factor levels in first episode of psychosis: A systematic review.
机构信息
Alba Toll, Anna Mané, Institut de Neuropsiquitria i Addiccions, Parc de Salut Mar, 08003 Barcelona, Spain.
出版信息
World J Psychiatry. 2015 Mar 22;5(1):154-9. doi: 10.5498/wjp.v5.i1.154.
Abstract
AIM
To systematically review studies measuring peripheric brain-derived neurotrophic factor (BDNF) levels on first-episode psychosis patients and variables related to them.
METHODS
A systematic search was made of articles published in the Medline database from 2002 up to June 2014. Included are original studies that report enzyme-linked immunosorbent assay measurement of BDNF levels in serum or plasma in patients with a diagnosis of first episode psychosis (FEP) and age- and gender- matched healthy controls.
RESULTS
Of the initially identified 147 articles, only 18 satisfied the inclusion criteria. Of this, 15 found a significant reduction in patients with FEP compared with age- and gender - matched controls.
CONCLUSION
Peripheral BDNF levels are generally reduced in FEP patients. There are some factors that may influence BDNF levels that need to be further studied. Furthermore, a future meta-analysis in this topic is needed.
摘要
目的
系统回顾外周脑源性神经营养因子（BDNF）水平测量首发精神分裂症患者及相关变量的研究。
方法
对 2002 年至 2014 年 6 月间 Medline 数据库发表的文章进行系统检索。纳入的原始研究报告了酶联免疫吸附测定法在血清或血浆中检测首发精神分裂症（FEP）患者和年龄及性别匹配的健康对照者外周 BDNF 水平的结果。
结果
最初确定的 147 篇文章中，仅有 18 篇符合纳入标准。其中，15 项研究发现 FEP 患者外周 BDNF 水平显著低于年龄和性别匹配的对照组。
结论
外周 BDNF 水平在首发精神分裂症患者中普遍降低。有一些可能影响 BDNF 水平的因素需要进一步研究。此外，该主题需要进行未来的荟萃分析。
相似文献
1
Brain-derived neurotrophic factor levels in first episode of psychosis: A systematic review.
World J Psychiatry. 2015 Mar 22;5(1):154-9. doi: 10.5498/wjp.v5.i1.154.
2
A Longitudinal Study of Serum Brain-Derived Neurotrophic Factor Levels in First-Episode Schizophrenia.
J Clin Psychopharmacol. 2019 Nov/Dec;39(6):639-643. doi: 10.1097/JCP.0000000000001118.
3
Peripheral Blood Levels of Brain-Derived Neurotrophic Factor in Patients with First Episode Psychosis: A Systematic Review and Meta-Analysis.
Brain Sci. 2022 Mar 22;12(4):414. doi: 10.3390/brainsci12040414.
4
Lower Brain-Derived Neurotropic Factor Levels in Untreated Adolescents With First-Episode Psychosis.
J Clin Psychopharmacol. 2015 Oct;35(5):596-9. doi: 10.1097/JCP.0000000000000378.
5
Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia.
Neuropsychobiology. 2010;62(2):87-90. doi: 10.1159/000315438. Epub 2010 Jun 3.
6
Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis.
Mol Psychiatry. 2011 Sep;16(9):960-72. doi: 10.1038/mp.2010.88. Epub 2010 Aug 24.
7
Plasma and serum brain-derived neurotrophic factor (BDNF) levels and their association with neurocognition in at-risk mental state, first episode psychosis and chronic schizophrenia patients.
World J Biol Psychiatry. 2019 Sep;20(7):545-554. doi: 10.1080/15622975.2018.1462532. Epub 2018 Jun 25.
8
Salivary cortisol in early psychosis: New findings and meta-analysis.
Psychoneuroendocrinology. 2016 Jan;63:262-70. doi: 10.1016/j.psyneuen.2015.10.007. Epub 2015 Oct 16.
9
Comparison of brain N-acetylaspartate levels and serum brain-derived neurotrophic factor (BDNF) levels between patients with first-episode schizophrenia psychosis and healthy controls.
Eur Psychiatry. 2011 Jan;26(1):57-63. doi: 10.1016/j.eurpsy.2009.10.001.
10
Levels of Serum Brain-Derived Neurotropic Factor in Individuals at Ultra-High Risk for Psychosis-Findings from the Longitudinal Youth at Risk Study (LYRIKS).
Int J Neuropsychopharmacol. 2018 Aug 1;21(8):734-739. doi: 10.1093/ijnp/pyy036.
引用本文的文献
1
Biomarkers for Psychosis: Are We There Yet? Umbrella Review of 1478 Biomarkers.
Schizophr Bull Open. 2024 Aug 30;5(1):sgae018. doi: 10.1093/schizbullopen/sgae018. eCollection 2024 Jan.
2
Relationship between thyroid-stimulating hormone, BDNF levels, and hippocampal volume in antipsychotic-naïve first-episode psychosis patients.
Front Psychiatry. 2023 Dec 7;14:1301714. doi: 10.3389/fpsyt.2023.1301714. eCollection 2023.
3
Neurotrophic Factors in Cannabis-induced Psychosis: An Update.
Curr Top Med Chem. 2024;24(20):1757-1772. doi: 10.2174/1568026623666230829152150.
4
The Effect of Zinc Supplementation on Circulating Levels of Brain-Derived Neurotrophic Factor (BDNF): A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Int J Prev Med. 2022 Sep 20;13:117. doi: 10.4103/ijpvm.IJPVM_478_20. eCollection 2022.
5
Can the Imbalance between Neurotrophic and Apoptotic Proteins Be the "Beware the Ides of March" for Unaffected Relatives of Schizophrenia Patients?
Mol Neurobiol. 2022 Dec;59(12):7413-7422. doi: 10.1007/s12035-022-03054-4. Epub 2022 Oct 3.
6
Association between brain-derived neurotropic factor (BDNF), high-sensitivity C-reactive protein (hs-CRP) and psychiatric symptoms in medicated and unmedicated patients.
BMC Psychiatry. 2022 Feb 3;22(1):84. doi: 10.1186/s12888-022-03744-2.
7
Multidimensional predictors of negative symptoms in antipsychotic-naive first-episode psychosis.
J Psychiatry Neurosci. 2022 Jan 19;47(1):E21-E31. doi: 10.1503/jpn.210138. Print 2022 Jan-Feb.
8
Exercise as a protective mechanism against the negative effects of oxidative stress in first-episode psychosis: a biomarker-led study.
Transl Psychiatry. 2020 Jul 24;10(1):254. doi: 10.1038/s41398-020-00927-x.
9
Cannabis use influence on peripheral brain-derived neurotrophic factor levels in antipsychotic-naïve first-episode psychosis.
Eur Arch Psychiatry Clin Neurosci. 2020 Oct;270(7):851-858. doi: 10.1007/s00406-020-01117-y. Epub 2020 Mar 17.
10
Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness.
Schizophr Res. 2020 Dec;226:13-23. doi: 10.1016/j.schres.2020.01.003. Epub 2020 Feb 20.
本文引用的文献
1
Interplay between childhood trauma and BDNF val66met variants on blood BDNF mRNA levels and on hippocampus subfields volumes in schizophrenia spectrum and bipolar disorders.
J Psychiatr Res. 2014 Dec;59:14-21. doi: 10.1016/j.jpsychires.2014.08.011. Epub 2014 Aug 30.
2
Brain-derived neurotrophic factor blood levels are decreased in schizophrenia patients and associate with rs6265 genotypes.
Clin Biochem. 2014 Aug;47(12):1052-5. doi: 10.1016/j.clinbiochem.2014.03.021. Epub 2014 Apr 5.
3
Vascular endothelial growth factor and brain-derived neurotrophic factor in quetiapine treated first-episode psychosis.
Schizophr Res Treatment. 2014;2014:719395. doi: 10.1155/2014/719395. Epub 2014 Feb 5.
4
BDNF serum concentrations in first psychotic episode drug-naïve schizophrenic patients: associations with personality and BDNF Val66Met polymorphism.
Life Sci. 2013 Mar 12;92(4-5):305-10. doi: 10.1016/j.lfs.2013.01.008. Epub 2013 Jan 15.
5
Plasma brain-derived neurotrophic factor levels, learning capacity and cognition in patients with first episode psychosis.
BMC Psychiatry. 2013 Jan 15;13:27. doi: 10.1186/1471-244X-13-27.
6
Association of serum BDNF and val66met polymorphism of the brain-derived neurotrophic factor in a sample of first psychotic episode patients.
Psychiatriki. 2009 Oct;20(4):297-304.
7
Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients.
Hum Psychopharmacol. 2012 Jan;27(1):33-8. doi: 10.1002/hup.1257. Epub 2011 Dec 30.
8
The role of BDNF in the pathophysiology and treatment of schizophrenia.
J Psychiatr Res. 2012 Jan;46(1):1-11. doi: 10.1016/j.jpsychires.2011.09.022. Epub 2011 Oct 26.
9
Association of serum BDNF levels with hippocampal volumes in first psychotic episode drug-naive schizophrenic patients.
Schizophr Res. 2011 Jul;129(2-3):201-4. doi: 10.1016/j.schres.2011.03.011. Epub 2011 Apr 5.
10
Age at onset of psychotic disorder: cannabis, BDNF Val66Met, and sex-specific models of gene-environment interaction.
Am J Med Genet B Neuropsychiatr Genet. 2011 Apr;156B(3):363-9. doi: 10.1002/ajmg.b.31174. Epub 2011 Feb 8.
Zotero 插件